{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,5]],"date-time":"2026-11-05T22:03:58Z","timestamp":1793916238254,"version":"4.8.0"},"reference-count":26,"publisher":"Wiley","issue":"3","license":[{"start":{"date-parts":[[2015,9,1]],"date-time":"2015-09-01T00:00:00Z","timestamp":1441065600000},"content-version":"tdm","delay-in-days":1748,"URL":"http:\/\/doi.wiley.com\/10.1002\/tdm_license_1.1"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2011,3]]},"DOI":"10.1111\/j.1469-8749.2010.03830.x","type":"journal-article","created":{"date-parts":[[2010,11,18]],"date-time":"2010-11-18T16:15:22Z","timestamp":1290096922000},"page":"239-244","source":"Crossref","is-referenced-by-count":33,"title":["Neuronox versus BOTOX for spastic equinus gait in children with cerebral palsy: a randomized, double-blinded, controlled multicentre clinical trial"],"prefix":"10.1111","volume":"53","author":[{"given":"KEEWON","family":"KIM","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"HYUNG-IK","family":"SHIN","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"BUM SUN","family":"KWON","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"SANG JUN","family":"KIM","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"IL-YOUNG","family":"JUNG","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"MOON SUK","family":"BANG","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2010,11,18]]},"reference":[{"key":"10.1111\/j.1469-8749.2010.03830.x-BIB1|cit1","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1097\/01241398-199307000-00013","article-title":"Management of cerebral palsy with botulinum-A toxin: preliminary investigation","volume":"13","author":"Koman","year":"1993","journal-title":"J Pediatr Orthop"},{"key":"10.1111\/j.1469-8749.2010.03830.x-BIB2|cit2","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1097\/01241398-199405000-00005","article-title":"Management of spasticity in cerebral palsy with botulinum-A toxin: report of a preliminary, randomized, double-blind trial","volume":"14","author":"Koman","year":"1994","journal-title":"J Pediatr Orthop"},{"key":"10.1111\/j.1469-8749.2010.03830.x-BIB3|cit3","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1111\/j.1469-8749.1994.tb11864.x","article-title":"Botulinum toxin in the management of the lower limb in cerebral palsy","volume":"36","author":"Cosgrove","year":"1994","journal-title":"Dev Med Child Neurol"},{"key":"10.1111\/j.1469-8749.2010.03830.x-BIB4|cit4","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1212\/01.wnl.0000316801.74683.c0","article-title":"Two-year placebo-controlled trial of botulinum toxin A for leg spasticity in cerebral palsy","volume":"71","author":"Moore","year":"2008","journal-title":"Neurology"},{"key":"10.1111\/j.1469-8749.2010.03830.x-BIB5|cit5","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1007\/s00702-008-0175-8","article-title":"Effectiveness of botulinum toxin A for upper and lower limb spasticity in children with cerebral palsy: a summary of evidence","volume":"116","author":"Lukban","year":"2009","journal-title":"J Neural Transm"},{"key":"10.1111\/j.1469-8749.2010.03830.x-BIB6|cit6","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1111\/j.1469-8749.2008.03264.x","article-title":"Long-term efficacy and tolerability of 4-monthly versus yearly botulinum toxin type A treatment for lower-limb spasticity in children with cerebral palsy","volume":"51","author":"Kanovsky","year":"2009","journal-title":"Dev Med Child Neurol"},{"key":"10.1111\/j.1469-8749.2010.03830.x-BIB7|cit7","doi-asserted-by":"crossref","first-page":"1658","DOI":"10.1002\/jor.20450","article-title":"Effects of BOTOX and Neuronox on muscle force generation in mice","volume":"25","author":"Stone","year":"2007","journal-title":"J Orthop Res"},{"key":"10.1111\/j.1469-8749.2010.03830.x-BIB8|cit8","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1186\/1741-7015-8-18","article-title":"CONSORT 2010 Statement: updated guidelines for reporting parallel group randomised trials","volume":"8","author":"Schulz","year":"2010","journal-title":"BMC Med"},{"key":"10.1111\/j.1469-8749.2010.03830.x-BIB9|cit9","doi-asserted-by":"crossref","first-page":"901","DOI":"10.1097\/PHM.0b013e3181520449","article-title":"Effects of botulinum toxin A therapy with electrical stimulation on spastic calf muscles in children with cerebral palsy","volume":"86","author":"Kang","year":"2007","journal-title":"Am J Phys Med Rehabil"},{"key":"10.1111\/j.1469-8749.2010.03830.x-BIB10|cit10","volume-title":"Botulinum Toxin Treatment of Muscle Spasticity","author":"Bakheit","year":"2007"},{"key":"10.1111\/j.1469-8749.2010.03830.x-BIB11|cit11","doi-asserted-by":"crossref","first-page":"1169","DOI":"10.1002\/sim.2244","article-title":"Choosing the analysis population in non-inferiority studies: per protocol or intent-to-treat","volume":"25","author":"Matilde Sanchez","year":"2006","journal-title":"Stat Med"},{"key":"10.1111\/j.1469-8749.2010.03830.x-BIB12|cit12","doi-asserted-by":"crossref","first-page":"1062","DOI":"10.1542\/peds.108.5.1062","article-title":"Botulinum toxin type a neuromuscular blockade in the treatment of equinus foot deformity in cerebral palsy: a multicenter, open-label clinical trial","volume":"108","author":"Koman","year":"2001","journal-title":"Pediatrics"},{"key":"10.1111\/j.1469-8749.2010.03830.x-BIB13|cit13","volume-title":"Gross Motor Function Measure (GMFM-66 & GMFM-88) User\u2019s Manual","author":"Russell","year":"2002"},{"key":"10.1111\/j.1469-8749.2010.03830.x-BIB14|cit14","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1002\/mds.870130128","article-title":"Variability of the immunologic and clinical response in dystonic patients immunoresistant to botulinum toxin injections","volume":"13","author":"Sankhla","year":"1998","journal-title":"Mov Disord"},{"key":"10.1111\/j.1469-8749.2010.03830.x-BIB15|cit15","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1136\/adc.83.6.481","article-title":"Randomized double blind placebo controlled trial of the effect of botulinum toxin on walking in cerebral palsy","volume":"83","author":"Ubhi","year":"2000","journal-title":"Arch Dis Child"},{"key":"10.1111\/j.1469-8749.2010.03830.x-BIB16|cit16","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1097\/00004694-200001000-00022","article-title":"Botulinum toxin type A neuromuscular blockade in the treatment of lower extremity spasticity in cerebral palsy: a randomized, double-blind, placebo-controlled trial. BOTOX Study Group","volume":"20","author":"Koman","year":"2000","journal-title":"J Pediatr Orthop"},{"key":"10.1111\/j.1469-8749.2010.03830.x-BIB17|cit17","doi-asserted-by":"crossref","first-page":"1903","DOI":"10.1002\/(SICI)1097-0258(19990815)18:15<1903::AID-SIM188>3.0.CO;2-F","article-title":"Statistical principles for clinical trials (ICH E9): an introductory note on an international guideline","volume":"18","author":"Lewis","year":"1999","journal-title":"Stat Med"},{"key":"10.1111\/j.1469-8749.2010.03830.x-BIB18|cit18","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1136\/bmj.300.6719.230","article-title":"Analysis of serial measurements in medical research","volume":"300","author":"Matthews","year":"1990","journal-title":"BMJ"},{"issue":"Suppl. 1","key":"10.1111\/j.1469-8749.2010.03830.x-BIB19|cit19","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1111\/j.1468-1331.2006.01438.x","article-title":"Pharmacology of botulinum toxin: differences between type A preparations","volume":"13","author":"Rosales","year":"2006","journal-title":"Eur J Neurol"},{"key":"10.1111\/j.1469-8749.2010.03830.x-BIB20|cit20","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1007\/BF03033927","article-title":"Neurophysiological effects of botulinum toxin type A","volume":"9","author":"Abbruzzese","year":"2006","journal-title":"Neurotox Res"},{"key":"10.1111\/j.1469-8749.2010.03830.x-BIB21|cit21","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1590\/S0004-282X2009000100016","article-title":"Botulinum toxin type A in the treatment of lower-limb spasticity in children with cerebral palsy","volume":"67","author":"Camargo","year":"2009","journal-title":"Arq Neuropsiquiatr"},{"key":"10.1111\/j.1469-8749.2010.03830.x-BIB22|cit22","doi-asserted-by":"crossref","first-page":"666","DOI":"10.1111\/j.1469-8749.2002.tb00268.x","article-title":"Botulinum toxin treatment of spasticity in diplegic cerebral palsy: a randomized, double-blind, placebo-controlled, dose-ranging study","volume":"44","author":"Baker","year":"2002","journal-title":"Dev Med Child Neurol"},{"key":"10.1111\/j.1469-8749.2010.03830.x-BIB23|cit23","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1046\/j.1468-1331.2001.00277.x","article-title":"A randomized, double-blind, placebo-controlled study of the efficacy and safety of botulinum toxin type A in upper limb spasticity in patients with stroke","volume":"8","author":"Bakheit","year":"2001","journal-title":"Eur J Neurol"},{"key":"10.1111\/j.1469-8749.2010.03830.x-BIB24|cit24","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1055\/s-2007-973475","article-title":"Botulinum toxin A in the management of spastic gait disorders in children and young adults with cerebral palsy: a randomized, double-blind study of \u201chigh-dose\u201d versus \u201clow-dose\u201d treatment","volume":"30","author":"Wissel","year":"1999","journal-title":"Neuropediatrics"},{"key":"10.1111\/j.1469-8749.2010.03830.x-BIB25|cit25","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1017\/S0012162206000041","article-title":"Treatment of adductor spasticity with BTX-A in children with CP: a randomized, double-blind, placebo-controlled study","volume":"48","author":"Mall","year":"2006","journal-title":"Dev Med Child Neurol"},{"key":"10.1111\/j.1469-8749.2010.03830.x-BIB26|cit26","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1017\/S0012162201000445","article-title":"Safety profile and efficacy of botulinum toxin A (Dysport) in children with muscle spasticity","volume":"43","author":"Bakheit","year":"2001","journal-title":"Dev Med Child Neurol"}],"container-title":["Developmental Medicine &amp; Child Neurology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1469-8749.2010.03830.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/onlinelibrary.wiley.com\/wol1\/doi\/10.1111\/j.1469-8749.2010.03830.x\/fullpdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,7,7]],"date-time":"2021-07-07T13:39:35Z","timestamp":1625665175000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/j.1469-8749.2010.03830.x"}},"subtitle":["Neuronox vs BOTOX for Spasticity in Cerebral Palsy"],"short-title":[],"issued":{"date-parts":[[2010,11,18]]},"references-count":26,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2011,3]]}},"URL":"https:\/\/doi.org\/10.1111\/j.1469-8749.2010.03830.x","relation":{},"ISSN":["0012-1622"],"issn-type":[{"value":"0012-1622","type":"print"}],"subject":[],"published":{"date-parts":[[2010,11,18]]}}}